Parexel, a provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world health, from Clinical through to Commercialization, has launched an enhanced integrated outsourcing delivery model for Functional Service Provider (FSP.)
Parexel FSP consists of more than 5,000 specialized employees across the globe with a track record of achieving a 95 percent success rate in delivering repeat business.
Parexel’s customizable functional service solutions include Global Clinical Operations, Global Data Operations, Pharmacovigilance, Medical Affairs, Medical Writing, and Regulatory Support.
Learn more at www.parexel.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.